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Abstract
Background: Porcine reproductive and respiratory syndrome virus (PRRSV) induces one of most important
devastating disease of swine worldwide, and the current methods poorly control it. Previous studies have
indicated that the nonstructural protein 11 (nsp11) of PRRSV may be an important protein for the immune
escape of PRRSV.
Results: Here, we firstly explored the effect of over-expression of nsp11 on PRRSV infection and found that
over-expression of nsp11 enhanced the PRRSV titers while the small interfering RNA (siRNAs) specifically targeting
nsp11 could reduce the PRRSV titers in MARC-145 cells.
Conclusion: In conclusion, PRRSV nsp11 promotes PRRSV infection in MARC-145 cells and siRNAs targeting nsp11 may
be a potential therapeutic strategy to control PRRSV in future.
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Background
PRRSV, a positive sense and single-stranded RNA virus,
is a member of family Arteriviridae [1]. Since it was
emerged in the United States in 1987 and in Europe in
1990, PRRSV has rapidly spread in the swine producing
regions and became one of the most important devas-
tating diseases of swine worldwide. It can cause se-
vere reproductive failure in sows and respiratory
distress in young growing pigs [2]. Infection with
PRRSV also made pigs easy to secondary infection by
other pathogens [3]. Up to date, since there is no efficient
method or drugs against PRRSV, it is very important and
urgent to develop the effective therapeutic strategies to
control PRRS.
The PRRSV genome has nine open reading frames
(ORFs) composed of ORF1a, ORF1b, ORF2a, ORF2b,
and ORF3-7. ORF1a and ORF1b could produce 16 non-
structural proteins (nsp1α, nsp1β, nsp2 etc.) [4–7]. Pre-
vious studies have shown that the nsp11 of equine
arteritis virus(EAV), which is another member of family
Arteriviridae, may play a key role in viral RNA synthe-
sis and additional functions in the viral life cycle [8].
Other and our previous work also demonstrated that
PRRSV nsp11 inhibited the host innate immune re-
sponses such as the transcription of type I interferon
[7], the RNAi innate immune response [9] and the NLR
family pyrin domain-containing 3 (NLRP3)-mediated
production of IL-1β [10], which indicated that PRRSV
nsp11 may play an important role in PRRSV infection.
So the purpose of present study is to explore the effect
of over-expression of nsp11 on PRRSV infection and
whether the siRNAs targeting the PRRSV nsp11 could
influence PRRSV infection.
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MARC-145 cells, derived from a monkey fibroblast cell
line MA-104 [11], and 293T cells were grown in Dulbec-
co’s Modified Eagle medium (Gibco) plus 10 % heat-
inactivated fetal bovine serum (Hyclone). PRRSV strain
BJ-4 was a kind gift from Prof. Hanchun Yang (China
Agricultural University).
Plasmids
The pcDNA3.1-GFP-nsp11 plasmid was constructed by
sub-cloning from the plasmid pcDNA3.1-FLAG-nsp11 [7]
to pcDNA3.1-GFP [12] using the restriction endonuclease
Hind III and EcoRI. The plasmids pcDNA3.1-FLAG,
pcDNA3.1-FLAG-nsp11 and pcDNA3.1-FLAG-nsp11
H129A have been described in our previous work [7].
Transfection of plasmids and viral infection
All newly-prepared plasmids were confirmed correctly
by DNA sequencing. Transient transfection was car-
ried out by using Lipofectamine 2000 (Invitrogen).
Cells cultured in 24-well plates were transfected with
the indicated expression plasmid or control vector
(800 ng/well) in triplicate. And 6 h (h) later, the cells
were infected with PRRSV at a multiplicity of infec-
tion (MOI) of 0.1, and then the cells were lysed by
freezing and thawing three times after 24 h infection.
The supernatants were collected by centrifugation,
and the viral titers were detected by 50 % tissue cul-
ture infected dose (TCID50) assay using the method
of Reed–Muench in the MARC-145 cells.
Western blots
The 293 T cells were cultured in 24-well plates and
transfected with pcDNA3.1-GFP-nsp11 or pcDNA3.1-
GFP and nsp11 siRNA (100 nM) or control siRNA
(100 nM) in triplicate, and 36 h later, the cells were
lysed with lysing buffer (1 % Nonidet P-40, 0.1 % so-
dium deoxycholate, 0.1 % SDS, 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 2 mM EDTA, 2 mM
Na3VO4, 2 mM NaF and a protease inhibitor
cocktail). The detailed procedure for immunoblots has
been described in our previous work [13]. Briefly, the
proteins were separated by 10 % SDS-PAGE and
transferred to polyvinylidene difluoride (PVDF) mem-
branes (Millipore Company, Boston, Massachusetts,
USA), and then the PVDF membranes were incubated
with anti-GFP (Clontech) or anti-actin (Cell Signaling
Technology) antibodies. Subsequently the membranes
were incubated with appropriate secondary antibodies
and were tested by an ECL detection system (Cell
Signaling Technology, Boston, USA).
Transfection of siRNA and viral infection
Cells cultured in 24-well plates were transfected with
the indicated siRNA in triplicate (100 nM/well) (chem-
ical synthesis by Bioneer) (Table. 1). And 6 h later, the
cells were infected with PRRSV strain BJ-4 at an MOI of
0.1, and 24 h later, the cells were lysed by freezing and
thawing three times. The supernatants were collected by
centrifugation, and the viral titers were detected by
TCID50 using the method of Reed–Muench in the
MARC-145 cells.
Real time (RT)-PCR
MARC-145 cells cultured in 24-well plates were trans-
fected in triplicate with nsp11-siRNAs/control siRNA
and plasmid pcDNA3.1-GFP-nsp11 (800 ng/well) or
pcDNA 3.1-GFP (800 ng/well). And 24 h later, the cells
were infected with PRRSV at an MOI of 0.1, and 48 h
later, the cellular RNA was extracted with TRIzol (Invi-
trogen). M-MLV reverse transcriptase was used for the
PrimeScript™ RT Reagent Kit with gDNA Eraser
(Takara, Dalian, China). Quantitative real-time RT-PCR
(qRT-PCR) was performed using SYBR® Premix Ex
Taq™ (Takara, Dalian, China) and was tested by the
7500 First real-time PCR system (Applied Biosystems,
Foster City, CA, USA). Glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) was used as an internal control.
The 2−ΔΔCt-method was used to analyze the relative
amount of target gene expression.
Table 1 Synthesized siRNAs sequences targeting the regions of PRRSV nsp11 and the primers of ORF-7 for RT-PCR
Gene of target Name of siRNA Location(bp) Sequence (5’-3’)
nsp 11 nsp11 siRNA 1 244-262 CGTGTCATACTATCTCACA
nsp 11 nsp11 siRNA 2 526-544 CACACTGACAGATGTGTAC
nsp 11 nsp11 siRNA 3 409-427 CACTACCGTTGGAGGATGT
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Viral titers
MARC-145 cells transfected with the nsp11 siRNA (100
nM) or control siRNA (100 nM) and the plasmid
pcDNA3.1-GFP-nsp11 (800 ng/well) or pcDNA3.1-GFP
(800 ng/well), and 24 h later, the cells were infected by
PRRSV at an MOI of 0.1, the cells were frozen and
thawed in three cycles and collected after 48 h infection.
Then the viral titers were determined by TCID50 assay
using the method of Reed–Muench in the cells of
MARC-145.
Statistical analysis
Statistical analyses were performed by Student’s t-test,
and the differences were considered as statistical signifi-
cance when P <0.05.
Results
Over-expression of nsp11 enhanced PRRSV titers in
MARC-145 cells
Firstly, we successfully constructed the expression
plasmid of pcDNA 3.1-GFP-nsp11 (GFP-nsp11) and
the western blot in Fig. 1a confirmed the successful
expression of GFP-nsp11 (Fig. 1). Secondly, the
MARC-145 cells were cultured in 24-well plates
overnight, and then the cells were transfected with
the expression plasmid pcDNA3.1-GFP-nsp11 or the
control plasmid pcDNA3.1-GFP. The results in Fig. 1b
showed that the PRRSV titers from the MARC-145
cells transfected with pcDNA3.1-GFP-nsp11 were
about one point six times to that from MARC-145
cells transfected with control plasmid, while the RNA
levels of PRRSV from the MARC-145 cells transfected
with pcDNA3.1-GFP-nsp11 were three times to that
from MARC-145 cells transfected with control plas-
mid (Fig. 1c).
siRNAs targeting nsp11 reduced PRRSV titers in MARC-145
cells
Now that over-expression of nsp11 could enhance
PRRSV titers, it was reasonable to design siRNAs tar-
geting nsp11 to investigate whether the siRNAs could
reduce PRRSV titers. The sequences of the siRNA
special for nsp11 and the control siRNA were listed
in Table 1. 293T cells (Fig. 2a) or MARC-145 cells
(Fig. 2b) grown in 24-well plates were co-transfected
with the nsp11 siRNA (100 nM/well) or control
siRNA and the plasmid GFP-nsp11 (800 ng/well).
Fig. 1 Over-expression of nsp11enhenced the titers of PRRSV. a 293T cells were transfected with pcDNA3.1-GFP (GFP) or pcDNA3.1-GFP-nsp11
(GFP-nsp11), and 48 h later, the cells were analyzed by western blots. b MARC-145 cells cultured in 24-well plate were transfected with pcDNA3.1-GFP-
nsp11 (nsp11)(800 ng/well) or pcDNA 3.1-GFP (Con). And 6 h later, the cells were infected with PRRSV at an MOI of 0.1 or mock infected, and 24 h later,
the cells were lysed by freezing and thawing three times in three cycles, then the viral titers were measured by TCID50. c MARC-145 cells cultured in
24-well plate were transfected with pcDNA 3.1-GFP-nsp11 (nsp11) (800 ng/well) or pcDNA3.1-GFP (Con). And 6 h later, the cells were infected with
PRRSV at an MOI of 0.1 or mock infected, and 24 h later, the cells were collected and the viral RNA levels were measured by RT-PCR. Data represented
means of three replicates, and experiments were repeated three times. Error bars represented the standard deviations. *: P <0.05 compared
with the results in control. MOI: multiplicity of infection
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And 24 h later, the cells in five random fields were
analyzed by fluorescence microscopy (50×) and only
one of them was shown in Fig. 2. The results in Fig. 2
showed that all of the three siRNAs targeting nsp11
could inhibit the expression of GFP-nsp11 and didn’t
influence on the expression of GFP.
Finally, we selected two siRNAs (siRNA1 and
siRNA2) targeting nsp11 to determine whether siR-
NAs targeting nsp11 could reduce PRRSV titers in
MARC-145 cell. The western blots results in Fig. 3a
confirmed that siRNA1 and siRNA2 could efficiently
reduce the nsp11 expression in 293T cells (Fig. 3a).
The results in Fig. 3b and c showed that siRNAs tar-
geting nucleic acid sequence of nsp11 could signifi-
cantly reduce viral titers of PRRSV (Fig. 3b) and
reduce RNA levels of PRRSV (Fig. 3c).
The endoribonuclease activity of nsp11 was important for
nsp11 to enhance the PRRSV titers
Our previous work has shown that the endoribonuclease
activity of nsp11 was important for nsp11 to inhibit the
transcription of IFN-β [7] and the secretion of IL-1β
Fig. 2 siRNAs targeting nsp11 could inhibit the expression of GFP- nsp11 and didn’t influence on the expression of GFP in 293T cells or
in MARC-145 cells. 293T cells (a) or MARC-145 cells (b) cultured in 24-well plates were co-transfected with pcDNA 3.1-GFP-nsp11(800 ng/well)
or pcDNA3.1-GFP (800 ng/well) and nsp11 siRNA 1 (100 nM), nsp11 siRNA 2 (100 nM), nsp11 siRNA 3(100 nM) or control siRNA (100 nM). And 24 h later,
the cells were analyzed by fluorescence microscopy (50×). Data represented means of three replicates, and experiments were repeated three times
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[10]. So next we investigated whether the endoribonu-
clease activity of nsp11 was important for nsp11 to pro-
mote the PRRSV infection. Nedialkova et al. showed that
His-129, His-144, and Lys-173 were the catalytic centers,
and mutating one of the three amino acids could abolish
its enzyme activity. The results in Fig. 4 showed that in-
activating the endoribonuclease activity made nsp11 not
promote the PRRSV infection.
Discussion
nsp11 was a multi-functional protein. Both our and
other previous studies have shown that PRRSV nsp11 is
an interferon antagonist [7, 14] and that nsp11 plays an
important role in viral RNA synthesis and in the viral
life cycle [8]. Our recent work also demonstrated that
PRRSV nsp11 inhibited the RNAi innate immune re-
sponse [9] and NLRP3-mediated production of IL-1β
[10]. While our present work showed that over expres-
sion of PRRSV nsp11 could enhance the titers of PRRSV
(Fig. 1), so our present work gave a directly evidence
that nsp11 was an important viral component for up-
regulating the PRRSV titers.
Identification of and targeting viral important compo-
nents is useful for developing viral vaccine and controlling
the virus. For example, both the nonstructural protein 1 of
influenza virus and the nonstructural protein 1 of mouse
hepatitis virus (MHV) were important for the viral viru-
lence respectively, and both the modified live-viral vac-
cines that deletion of nonstructural protein 1 resulted in
complete protection against challenge with influenza virus
infection and MHV infection respectively [15–17].
RNA interference (RNAi) is an exciting method to si-
lence viral genes. Inhibition of specific genes by siRNA
has proven to be a potential therapeutic strategy against
viral infection [18], especially for the positive single
stranded RNA viruses since their genomes function as
both the mRNA and the replication template [19, 20].
Up to date, RNAi has been used against several viruses
such as hepatitis B virus, foot-and-mouth disease virus,
dengue virus and so on [20–22]. In this work, we also
explore whether the siRNA, which targeted the nucleic
acid sequence of nsp11, influenced the titers of PRRSV,
Fig. 3 siRNAs targeting nsp11 could efficiently reduce the titers of PRRSV. a 293T cells grown in 24-well plates were transfected with pcDNA3.1-
GFP-nsp11(800 ng/well) or pcDNA3.1-GFP (800 ng/well) and nsp11 siRNA 1 (100 nM), nsp11 siRNA 2 (100 nM) or control siRNA (100 nM), then
36 h later, the cells for collected for the western blot. b MARC-145 cells cultured in 24-well plates were transfected with nsp11 siRNA 1 (100 nM),
nsp11 siRNA 2 (100 nM) or control siRNA (100 nM). And 6 h later, the cells were infected with PRRSV at an MOI of 0.1 or mock infected, and 24 h
later, the cells were lysed by freezing and thawing three times, then the viral titers were measured by TCID50. c MARC-145 cells grown in 24-well
plates were transfected with nsp11 siRNA 1 (100 nM), nsp11 siRNA 2 (100 nM) or control siRNA (100 nM). And 6 h later, the cells were infected
with PRRSV at an MOI of 0.1 or mock infected, and 24 h later, the cells were collected and the viral RNA levels were measured by RT-PCR. Data
represented means of three replicates, and experiments were repeated three times. Error bars represented the standard deviations. *: P <0.05
compared with the results in control. MOI, multiplicity of infection
Fig. 4 The endoribonuclease activity of nsp11 was important for
nsp11 to enhance the PRRSV titers. MARC-145 cells cultured in
24-well plate were transfected with pcDNA3.1-FLAG-nsp11 (nsp11)
(800 ng/well), pcDNA3.1-FLAG-nsp11 H129A (nsp11 H129A) (800 ng/
well) or pcDNA 3.1-FLAG (Con). And 6 h later, the cells were infected
with PRRSV at an MOI of 0.1 or mock infected, and 24 h later, the cells
were lysed by freezing and thawing three times in three cycles, then
the viral titers were measured by TCID50. Data represented means of
three replicates, and experiments were repeated three times. Error bars
represented the standard deviations. *: P <0.05 compared with
the results in control. MOI, multiplicity of infection
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and the results showed that siRNA targeting nsp11 sig-
nificantly reduced the titers of PRRSV (Fig. 3). A recent
improved live PRRSV vaccine has indicated that the
ORF1a and ORF1b were the virulence determinants of
PRRSV [23]. In addition, our recent work also show that
RNAi innate immune response was an antiviral response
to PRRSV and PRRSV inhibited this response by PRRSV
nsp1α and nsp11, which indicated that targeting nsp11
would be useful for RNAi innate immunity against
PRRSV [9]. So it is reasonable to propose that our
present results gave a new clue for generating the new
PRRSV vaccine by targeting PRRSV nsp11.
Conclusion
In conclusion, our present study has shown that nsp11
was an important viral component for up-regulating the
titers of PRRSV and that siRNAs directly targeting
nsp11 could inhibit PRRSV infection, which indicated
that PRRSV nsp11 may be an interesting target for con-
trolling PRRSV in future.
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